Yahoo Web Search

Search results

    • Novo Slides as Amgen Fuels Obesity Drug Competition Fears

      Bloomberg· 27 minutes ago

      Have a confidential tip for our reporters? Novo Nordisk A/S shares slid on Friday as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing field.